ITTO20040682A1 - Formulazione per somministrazione orale avente un effetto salutistico sull'apparato cardiovascolare - Google Patents

Formulazione per somministrazione orale avente un effetto salutistico sull'apparato cardiovascolare

Info

Publication number: ITTO20040682A1
Authority: IT; Italy
Prior art keywords: effect; oral administration; salutistic; formulation; health
Prior art date: 2004-10-07

Application number

IT000682A

Other languages

English (en)

Inventor

Angelo Luigi Rovati

Paolo Senin

Ivo Setnikar

Original Assignee

Rottapharm S R L

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-10-07

Filing date

2004-10-07

Publication date

2005-01-07

2004-10-07 Application filed by Rottapharm S R L filed Critical Rottapharm S R L

2004-10-07 Priority to IT000682A priority Critical patent/ITTO20040682A1/it

2005-01-07 Publication of ITTO20040682A1 publication Critical patent/ITTO20040682A1/it

2005-09-20 Priority to DE602005007380T priority patent/DE602005007380D1/de

2005-09-20 Priority to PL05792107T priority patent/PL1827136T3/pl

2005-09-20 Priority to DK05792107T priority patent/DK1827136T3/da

2005-09-20 Priority to ES05792107T priority patent/ES2308550T3/es

2005-09-20 Priority to PCT/EP2005/054691 priority patent/WO2006037725A1/en

2005-09-20 Priority to PT05792107T priority patent/PT1827136E/pt

2005-09-20 Priority to EP05792107A priority patent/EP1827136B1/en

2005-09-20 Priority to SI200530379T priority patent/SI1827136T1/sl

2005-09-20 Priority to US11/576,644 priority patent/US20080102082A1/en

2005-09-20 Priority to AT05792107T priority patent/ATE397389T1/de

2005-10-05 Priority to TW094134749A priority patent/TWI359667B/zh

2008-09-03 Priority to CY20081100945T priority patent/CY1108314T1/el

Links

239000000203 mixture Substances 0.000 title abstract 4
230000000694 effects Effects 0.000 title abstract 2
230000002526 effect on cardiovascular system Effects 0.000 title 1
238000009472 formulation Methods 0.000 title 1
OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 abstract 2
230000008821 health effect Effects 0.000 abstract 2
UOTMYNBWXDUBNX-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinolin-2-ium;chloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 UOTMYNBWXDUBNX-UHFFFAOYSA-N 0.000 abstract 1
JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 abstract 1
ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 abstract 1
OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 abstract 1
230000003078 antioxidant effect Effects 0.000 abstract 1
235000013793 astaxanthin Nutrition 0.000 abstract 1
MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 abstract 1
229940022405 astaxanthin Drugs 0.000 abstract 1
239000001168 astaxanthin Substances 0.000 abstract 1
210000000748 cardiovascular system Anatomy 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
235000017471 coenzyme Q10 Nutrition 0.000 abstract 1
ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 abstract 1
229940110767 coenzyme Q10 Drugs 0.000 abstract 1
235000015872 dietary supplement Nutrition 0.000 abstract 1
210000003038 endothelium Anatomy 0.000 abstract 1
235000019152 folic acid Nutrition 0.000 abstract 1
229960000304 folic acid Drugs 0.000 abstract 1
239000011724 folic acid Substances 0.000 abstract 1
229940057059 monascus purpureus Drugs 0.000 abstract 1
229960001109 policosanol Drugs 0.000 abstract 1
BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 abstract 1
230000001681 protective effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/60—Edible seaweed
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B67/00—Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
- C09B67/0097—Dye preparations of special physical nature; Tablets, films, extrusion, microcapsules, sheets, pads, bags with dyes
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Mycology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Natural Medicines & Medicinal Plants (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Nutrition Science (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Botany (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Alternative & Traditional Medicine (AREA)
Medical Informatics (AREA)
Zoology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Marine Sciences & Fisheries (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IT000682A 2004-10-07 2004-10-07 Formulazione per somministrazione orale avente un effetto salutistico sull'apparato cardiovascolare ITTO20040682A1 (it)

Priority Applications (13)

Application Number	Priority Date	Filing Date	Title
IT000682A ITTO20040682A1 (it)	2004-10-07	2004-10-07	Formulazione per somministrazione orale avente un effetto salutistico sull'apparato cardiovascolare
AT05792107T ATE397389T1 (de)	2004-10-07	2005-09-20	Formulierung für die orale verabreichung mit gesundheitsfördernder wirkung auf das herz- kreislauf-system
ES05792107T ES2308550T3 (es)	2004-10-07	2005-09-20	Formulacion para administracion oral que ejerce un efecto reconstituyente sobre el sistema cardiovascular.
PL05792107T PL1827136T3 (pl)	2004-10-07	2005-09-20	Preparat do podawania doustnego korzystnie wpływający na układ sercowo-naczyniowy
DK05792107T DK1827136T3 (da)	2004-10-07	2005-09-20	Sammensætning til oral indgivelse med sundhedsfremmende virkning på hjerte-kredslöbs-systemet
DE602005007380T DE602005007380D1 (de)	2004-10-07	2005-09-20	Formulierung für die orale verabreichung mit gesundheitsfördernder wirkung auf das herz-kreislauf-system
PCT/EP2005/054691 WO2006037725A1 (en)	2004-10-07	2005-09-20	Formulation for oral administration having a health-promoting effect on the cardiovascular system
PT05792107T PT1827136E (pt)	2004-10-07	2005-09-20	Formulação para administração oral que tem um efeito benéfico no sistema cardiovascular
EP05792107A EP1827136B1 (en)	2004-10-07	2005-09-20	Formulation for oral administration having a health-promoting effect on the cardiovascular system
SI200530379T SI1827136T1 (sl)	2004-10-07	2005-09-20	Formulacija za oralno dajanje, ki ima za zdravje koristen učinek na kardiovaskularni sistem
US11/576,644 US20080102082A1 (en)	2004-10-07	2005-09-20	Formulation for Oral Administration Having a Health-Promoting Effect on the Cardiovascular System
TW094134749A TWI359667B (en)	2004-10-07	2005-10-05	Formulation for oral administration having a healt
CY20081100945T CY1108314T1 (el)	2004-10-07	2008-09-03	Σκευασμα για στοματικη χορηγηση εχοντας μια δραση που προαγει την υγεια επι του καρδιαγγειακου συστηματος

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT000682A ITTO20040682A1 (it)	2004-10-07	2004-10-07	Formulazione per somministrazione orale avente un effetto salutistico sull'apparato cardiovascolare

Publications (1)

Publication Number	Publication Date
ITTO20040682A1 true ITTO20040682A1 (it)	2005-01-07

Family

ID=35395774

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IT000682A ITTO20040682A1 (it)	2004-10-07	2004-10-07	Formulazione per somministrazione orale avente un effetto salutistico sull'apparato cardiovascolare

Country Status (13)

Country	Link
US (1)	US20080102082A1 (it)
EP (1)	EP1827136B1 (it)
AT (1)	ATE397389T1 (it)
CY (1)	CY1108314T1 (it)
DE (1)	DE602005007380D1 (it)
DK (1)	DK1827136T3 (it)
ES (1)	ES2308550T3 (it)
IT (1)	ITTO20040682A1 (it)
PL (1)	PL1827136T3 (it)
PT (1)	PT1827136E (it)
SI (1)	SI1827136T1 (it)
TW (1)	TWI359667B (it)
WO (1)	WO2006037725A1 (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI323312B (en) *	2005-06-23	2010-04-11	Honda Motor Co Ltd	Gas-liquid separation device of engine
ITTO20060239A1 (it)	2006-03-30	2007-09-30	Rotthapharm S P A	Formulazione per somministrazione orale con effetti salutistici sull'apparato cardiovascolare
US20120171285A1 (en) *	2007-06-01	2012-07-05	Opheim Joar A	Substances for reducing occurrence of major cardiac events comprising omega-3 polyunsaturated fatty acid or derivatives thereof and high-monacolin k content red yeast rice extract
US20100119600A1 (en)	2007-06-01	2010-05-13	Joar Opheim	Substances for reducing occurrence of major cardiac events comprising red yeast rice extract and omega-3 polyunsaturated fatty acid or derivative thereof
FR2950061B1 (fr)	2009-09-11	2013-12-20	Coatex Sas	Monomeres associatifs a base de polycosanols, epaississants associatifs correspondants et leurs utilisations
ITMI20121696A1 (it) *	2012-10-09	2014-04-10	Ddf Group S A S	Composizioni per il trattamento delle iperlipidemie
ITUB20150541A1 (it)	2015-03-03	2016-09-03	Acraf	Composizione comprendente sostanze e/o estratti naturali
CN105878801A (zh) *	2016-05-10	2016-08-24	胡铭	一种具有降血脂作用的红曲虾青素组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5952393A (en) *	1998-02-12	1999-09-14	Sorkin, Jr.; Harlan Lee	Composition for reducing serum cholesterol levels
US20030104090A1 (en) *	2000-05-05	2003-06-05	Levy Pedro E.	Supplements containing annatto extracts and carotenoids and methods for using the same
US6436406B1 (en) *	2000-06-15	2002-08-20	A. Glenn Braswell	Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis
US6300377B1 (en) *	2001-02-22	2001-10-09	Raj K. Chopra	Coenzyme Q products exhibiting high dissolution qualities
US20030054978A1 (en) *	2001-08-31	2003-03-20	Babish John G.	Arginine compositions for coordinate modification of multiple cardiovascular risk factors

2004
- 2004-10-07 IT IT000682A patent/ITTO20040682A1/it unknown
2005
- 2005-09-20 DE DE602005007380T patent/DE602005007380D1/de not_active Expired - Lifetime
- 2005-09-20 PT PT05792107T patent/PT1827136E/pt unknown
- 2005-09-20 US US11/576,644 patent/US20080102082A1/en not_active Abandoned
- 2005-09-20 ES ES05792107T patent/ES2308550T3/es not_active Expired - Lifetime
- 2005-09-20 AT AT05792107T patent/ATE397389T1/de active
- 2005-09-20 EP EP05792107A patent/EP1827136B1/en not_active Expired - Lifetime
- 2005-09-20 DK DK05792107T patent/DK1827136T3/da active
- 2005-09-20 WO PCT/EP2005/054691 patent/WO2006037725A1/en not_active Ceased
- 2005-09-20 SI SI200530379T patent/SI1827136T1/sl unknown
- 2005-09-20 PL PL05792107T patent/PL1827136T3/pl unknown
- 2005-10-05 TW TW094134749A patent/TWI359667B/zh not_active IP Right Cessation
2008
- 2008-09-03 CY CY20081100945T patent/CY1108314T1/el unknown

Also Published As

Publication number	Publication date
ATE397389T1 (de)	2008-06-15
ES2308550T3 (es)	2008-12-01
DK1827136T3 (da)	2008-09-15
DE602005007380D1 (de)	2008-07-17
CY1108314T1 (el)	2014-02-12
EP1827136B1 (en)	2008-06-04
PL1827136T3 (pl)	2008-11-28
PT1827136E (pt)	2008-09-09
TW200621272A (en)	2006-07-01
TWI359667B (en)	2012-03-11
EP1827136A1 (en)	2007-09-05
SI1827136T1 (sl)	2008-12-31
US20080102082A1 (en)	2008-05-01
WO2006037725A1 (en)	2006-04-13

Publication	Publication Date	Title
ATE547098T1 (de)	2012-03-15	Orale formulierung mit vorteilhaften kardiovaskulären wirkungen und berberin-gehalt
CY1108314T1 (el)	2014-02-12	Σκευασμα για στοματικη χορηγηση εχοντας μια δραση που προαγει την υγεια επι του καρδιαγγειακου συστηματος
WO2008063910A3 (en)	2009-06-18	Method of preparing solid dosage forms of multi-phasic pharmaceutical compositions
WO2008153945A3 (en)	2009-02-12	Nutraceutical co-crystal compositions
PH12012502279A1 (en)	2017-08-09	Tube feed formulations and methods for using same
WO2020064946A3 (en)	2020-05-07	Compositions and methods using at least one glycine or derivative thereof, at least one n-acetylcysteine or derivative thereof, and at least one nicotinamide riboside or nad+ precursor
TW200744665A (en)	2007-12-16	Vitamin E succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
WO2012001074A3 (en)	2012-03-22	Pharmaceutical compositions comprising 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactate monohydrate
WO2007123995A3 (en)	2008-09-18	Camptothecin-analog with a novel, “flipped” lactone-stable, e-ring and methods for making and using same
WO2004069203A3 (en)	2005-02-03	Oral compositions of fenretinide having increased bioavailability and methods of using the same
WO2010041832A3 (ko)	2010-07-29	패 유래 화합물 함유 항산화 활성 조성물
CA2578881A1 (en)	2007-07-18	Vitamin d compositions and method of administration to a human being
MY209656A (en)	2025-07-29	Compositions and methods of enhancing 5-hydroxytryptophan bioavailability
WO2006032115A3 (en)	2006-08-03	Composition against cardiovascular diseases
WO2011141113A3 (de)	2012-01-05	Kombination aus vitamin k und nikotinamid
TW200420304A (en)	2004-10-16	Orally administrable pharmaceutical compositions and methods for preventing food-drug interaction
WO2012058276A3 (en)	2012-07-12	Methods and materials for reducing mutiple risk factors associated with the metabolic syndrom
WO2012143857A8 (en)	2013-11-21	Combination of carotenoid, phytooestrogen and vitamin c for moisturizing the skin
WO2016014680A8 (en)	2016-04-28	Oral transmucosal compositions including aromatase inhibitors for low testosterone levels in men
US20210069282A1 (en)	2021-03-11	Nutritional supplements affecting mood state and sleep quality
WO2006110924A3 (en)	2009-04-16	Dietary supplement formulations for improved delivery of coenzyme q10 and methods of administration
AU2566400A (en)	2000-08-18	Pharmaceutical combination of progesterone and folic acid
WO2009044548A1 (ja)	2009-04-09	抗下痢症組成物及びその含有物と下痢症予防方法
WO2006127759A3 (en)	2007-06-07	Antioxidant supplement composition and method of use
IN2015DN03082A (it)	2015-10-02